Nontuberculous mycobacteria (NTM) in Cystic fibrosis (CF) patients over the last decade: real-life data from Verona CF center Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Retrospective cohort study of adult cystic fibrosis patients colonised with achromobacter Xylosoxidans Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Non-tuberculous mycobacteria management in adult patients with Cystic Fibrosis: a retrospective study Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009
Bronchiectasis caused by pulmonary tuberculosis: The epidemiology, clinical presentations and the differences from non-tuberculosis-caused bronchiectasis Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Nontuberculous mycobacteria infection in patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Audit on the MRSA infection in adults with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004
PG18 Cystic fibrosis: management in adult patients Source: Paris 2018 - Educational material Year: 2018
Prevalence and reservoirs of A. xylosoxidans and S. maltophilia in cystic fibrosis center Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
The spectrum of Nocardia lung disease in cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Non tuberculous mycobacteria (NTM) contamination in a hospital water supply network: Association with pulmonary infection in respiratory wards Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015